Impact of donor age and recipient status on left-lobe graft for living donor adult liver transplantation
- PMID: 17887958
- DOI: 10.1111/j.1432-2277.2007.00561.x
Impact of donor age and recipient status on left-lobe graft for living donor adult liver transplantation
Abstract
Donor safety is the priority when performing a living donor adult liver transplantation (LDALT). We herein present our findings using left-lobe graft in LDALT. Data on 119 recipients who underwent the LDALT, and on 119 donors who underwent extended left lobectomy were reviewed. The recipients were divided into groups above (n = 19) and below (n = 100) 50 years of donor age, into groups above (n = 63) and below (n = 56) 40% of graft size (graft volume/standard liver volume, GV/SLV), and above (n = 25) and below (n = 94) 20 of pre-operative model for end-stage liver disease (MELD). Total bilirubin (TB), volume of ascites, prothrombin time international normalized ratio on postoperative day 14 or survival rates were compared. TB (mg/dl) or volume of ascites (ml) of the group in donor age < 50 years was better than that of the group in donor age > or = 50 years (7.4 vs. 14.7 or 788 vs. 1379, P < 0.001 or P < 0.005, respectively). The graft and patient survival rates of the lower MELD group tended to be better than that of the higher MELD group. LDALT can be safely performed using a left-lobe graft. However, when using the graft from the donor > or = 50 years, especially for the recipients with the MELD > or = 20, the indications should be carefully discussed.
Similar articles
-
Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.Liver Transpl. 2003 Jul;9(7):737-40. doi: 10.1053/jlts.2003.50122. Liver Transpl. 2003. PMID: 12827562
-
Prognosis of adult patients transplanted with liver grafts < 35% of their standard liver volume.Liver Transpl. 2009 Nov;15(11):1622-30. doi: 10.1002/lt.21716. Liver Transpl. 2009. PMID: 19877227
-
A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.Liver Transpl. 2009 Dec;15(12):1776-82. doi: 10.1002/lt.21955. Liver Transpl. 2009. PMID: 19938139
-
Management of the middle hepatic vein and its tributaries in right lobe living donor liver transplantation.Hepatobiliary Pancreat Dis Int. 2007 Aug;6(4):358-63. Hepatobiliary Pancreat Dis Int. 2007. PMID: 17690029 Review.
-
[Problems of living-related partial liver transplantation to adult patients].Rinsho Byori. 1996 Aug;44(8):715-25. Rinsho Byori. 1996. PMID: 8816056 Review. Japanese.
Cited by
-
Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End-Stage Liver Disease and Hepatorenal Syndrome.Hepatology. 2021 Jun;73(6):2441-2454. doi: 10.1002/hep.31584. Epub 2021 May 4. Hepatology. 2021. PMID: 33006772 Free PMC article.
-
Update on liver transplantation-newer aspects.Turk J Med Sci. 2020 Nov 3;50(SI-2):1642-1650. doi: 10.3906/sag-2002-17. Turk J Med Sci. 2020. PMID: 32222125 Free PMC article. Review.
-
Prediction and management of small-for-size syndrome in living donor liver transplantation.Clin Mol Hepatol. 2025 Feb;31(Suppl):S301-S326. doi: 10.3350/cmh.2024.0870. Epub 2024 Dec 10. Clin Mol Hepatol. 2025. PMID: 39657750 Free PMC article. Review.
-
Living Donor Liver Transplantation for Adults With High Model for End-stage Liver Disease Score: The US Experience.Transplantation. 2024 Mar 1;108(3):713-723. doi: 10.1097/TP.0000000000004767. Epub 2023 Aug 28. Transplantation. 2024. PMID: 37635282 Free PMC article.
-
Early graft dysfunction following adult-to-adult living-related liver transplantation: predictive factors and outcomes.World J Gastroenterol. 2009 Sep 28;15(36):4556-60. doi: 10.3748/wjg.15.4556. World J Gastroenterol. 2009. PMID: 19777614 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical